Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Category Archives: Respiratory
Rapid Update 1 – June 2017: COPD: New Cochrane review compares LAMA+LABA and LABA+ICS
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 3 – January 2017: Asthma – the importance of diagnosis and reassessment
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 2 – December 2016: Chronic obstructive pulmonary disease (COPD) – update on tiotropium inhalers
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 1 – December 2016: Long-term oxygen in COPD: Time to revisit?
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 3 – November 2016: COPD: Update to GOLD COPD guideline
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – see ‘register’ link at the top of this page.”
Rapid Update 2 – October 2016: Antibiotic Prescribing: Development and internal validation of a practical tool for primary care antimicrobial stewardship in children (STARWAVe)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 1 – October 2016: Asthma: Cochrane review finds vitamin D supplements may lower risk of severe asthma exacerbations
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
COPD: LABA/LAMA indacaterol/glycopyrronium reduces risk of exacerbations compared with LABA/ICS salmeterol/fluticasone (Jun-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – see ‘register’ link at the top of this page.
Asthma – importance of providing frequently repeated counselling on inhaler technique (Dec-15)
Authorised users need to be logged in to read this content.